Copilot
Your everyday AI companion
Bing found the following results
  1. What is the prognosis for extensive small cell lung cancer?

    Answered by verified global health professionals

    Dr. Sravya Vuppalapati

    Dr. Sravya Vuppalapati community pageMBBS · 1 years of expThe prognosis for extensive small cell lung cancer is generally less optimistic. This type of cancer tends to...Read more
    Was this helpful?
    Explore
  2. Prognosis for small cell lung cancer (SCLC) varies based on the stage123:
    • Limited-stage SCLC: Median overall survival is 20 months.
    • Extensive-stage SCLC: Median overall survival is 8–12 months.
    • Early-stage localized SCLC: 5-year survival rate is 27%.
    • Advanced-stage SCLC: 5-year survival rate can drop to 3%.
    • Overall 5-year survival rate for SCLC: 7%.
    Learn more:
    Regardless of stage, the prognosis for patients with SCLC is unsatisfactory despite improvements in diagnosis and therapy during the past 25 years. Without treatment, SCLC has the most aggressive clinical course of any type of pulmonary tumor, with a median survival from diagnosis of only 2 to 4 months.
    www.cancer.gov/types/lung/hp/small-cell-lung-treat…
    A 2018 review notes that the median overall survival is 20 months for limited-stage SCLC and 8–12 months for extensive-stage SCLC.
    www.healthline.com/health/small-cell-lung-cancer/r…
    The American Cancer Society notes that the 5-year survival rate for SCLC detection in the early stage when the cancer is localized is 27%. If the cancer has spread to distant parts of the body before detection, that 5-year survival rate can drop to 3%. The overall 5-year survival rate for SCLC is 7%.
    www.medicalnewstoday.com/articles/small-cell-lun…
  3. People also ask
    In general, a lower number stage of small cell lung cancer (SCLC) is linked with a better outcome. However, no doctor can predict how long a patient will live with SCLC based only on the stage of disease because it is different in each person, and treatment works differently for each tumor.
    primaryExpertImage

    Dr. Himanshu J. Vats

    Doctor of Medicine (MBBS) · 1.5 years of exp

    Small cell lung cancer (SCLC) is a fast-growing type of lung cancer that can spread quickly to other parts of the body. The treatment and survival rate for SCLC depends on the stage of the cancer at the time of diagnosis. For people with limited-stage SCLC, the five-year survival rate is about 30%. This means that about 30% of people with limited-stage SCLC will live for at least five years after diagnosis. For people with extensive-stage SCLC, the five-year survival rate is about 5%. This means that about 5% of people with extensive-stage SCLC will live for at least five years after diagnosis. The treatment for SCLC usually includes chemotherapy and radiation therapy. In some cases, surgery may also be an option.
    Q&A: Lung Cancer
    microsoftstart.msn.com
    Small cell lung cancer (SCLC) is the less common and more aggressive form. Five-year survival rates for SCLC vary depending on the stage, but the average is about 7% survival after 5 years. Survival rates will depend on the stage of cancer and how well a person responds to treatment.
    Knowing the stage helps the doctor recommend the best kind of treatment and can help predict a patient’s prognosis, which is the chance of recovery. There are different stage descriptions for different types of cancer. In general, a lower number stage of small cell lung cancer (SCLC) is linked with a better outcome.
  4. SCLC: A Fast-Growing Lung Cancer
    Small cell lung cancer (SCLC) is a fast-growing type of lung cancer that usually starts in the bronchi, the airways that connect the lungs to the windpipe.
    Feedback